Paul M. Harari, MD close
Paul M. Harari, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Paul M. Harari, MD Print Friendly Page

Chair, Department of Human Oncology
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Harari’s medical interests include radiation oncology, head and neck oncology, and oncology training and education.



UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency University of Arizona Medical Center, Tuscon, AZ
Internship University of California-Davis Medical Center, Sacramento, CA
Medical School University of Virginia School of Medicine, Charlottesville, VA

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Harari's clinical and laboratory research focuses on treatment advances for head and neck cancer patients through precision radiation techniques and the use of molecular targeted growth inhibitors combined with radiation.

PubMed Articles
Thomson DJ Palma D Guckenberger M Balermpas P Beitler JJ Blanchard P Brizel D Budach W Caudell J Corry J Corvo R Evans M Garden AS Giralt J Gregoire V Harari PM Harrington K Hitchcock YJ Johansen J Kaanders J Koyfman S Langendijk JA Le QT Lee N Margalit D Mierzwa M Porceddu S Soong YL Sun Y Thariat J Waldron J Yom SS Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement. Int J Radiat Oncol Biol Phys . 2020 Jul 15;107(4):618-627
[PubMed ID: 32302681]
Fisher MM SenthilKumar G Hu R Goldstein S Ong IM Miller MC Brennan SR Kaushik S Abel L Nickel KP Iyer G Harari PM Kimple RJ Baschnagel AM Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas. Int J Radiat Oncol Biol Phys . 2020 Jul 15;107(4):793-803
[PubMed ID: 32298810]
Lugo-Cintrón KM Ayuso JM White BR Harari PM Ponik SM Beebe DJ Gong MM Virumbrales-Muñoz M Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment. Lab Chip . 2020 May 7;20(9):1586-1600
[PubMed ID: 32297896]
Jagodinsky JC Harari PM Morris ZS The Promise of Combining Radiation Therapy With Immunotherapy. Int J Radiat Oncol Biol Phys . 2020 Apr 23;
[PubMed ID: 32335187]
Witek ME Harari PM Emphasize Treatment of Known Disease Rather Than Past Footprints. Int J Radiat Oncol Biol Phys . 2020 Apr 1;106(5):904
[PubMed ID: 32171461]
Burr AR Harari PM Haasl AM Wieland AM Bruce JY Kimple RJ Hartig GK McCulloch TM Witek ME Clinical outcomes for larynx patients with cancer treated with refinement of high-dose radiation treatment volumes. Head Neck . 2020 Feb 14;
[PubMed ID: 32057151]
Ayuso JM Gong MM Skala MC Harari PM Beebe DJ Human Tumor-Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells. Adv Healthc Mater . 2020 Feb;9(3):e1900925
[PubMed ID: 31894641]
Rydzewski NR Harari PM Hartig GK Francis D Witek ME Clinical Implications of Scleroderma in the Decision for Radiotherapy-Based Larynx Preservation. JAMA Otolaryngol Head Neck Surg . 2019 Dec 12;
[PubMed ID: 31830220]
Shaverdian N Yeboa DN Gardner L Harari PM Liao K McCloskey S Tuli R Vapiwala N Jagsi R Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences. J Oncol Pract . 2019 Dec;15(12):e1010-e1017
[PubMed ID: 31747336]
Gong MM Lugo-Cintron KM White BR Kerr SC Harari PM Beebe DJ Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function. Biomaterials . 2019 Sep;214:119225
[PubMed ID: 31154151]
Harari PM Open the Gates for Treatment De-Intensification in Head and Neck Cancer. J Clin Oncol . 2019 Aug 1;37(22):1854-1855
[PubMed ID: 31194612]
Thompson JD Avey GD Wieland AM Harari PM Glazer TA McCulloch TM Hartig GK Auriculotemporal Nerve Involvement in Parotid Bed Malignancy. Ann Otol Rhinol Laryngol . 2019 Jul;128(7):647-653
[PubMed ID: 30894024]
Burr AR Harari PM Ko HC Bruce JY Kimple RJ Witek ME Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer. Oral Oncol . 2019 May;92:52-56
[PubMed ID: 31010623]
Bowen RC Ko HC Avey GD Hartig GK Hu R Harari PM Lucarelli MJ Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review. Pract Radiat Oncol . 2019 May;9(3):136-141
[PubMed ID: 30731273]
Gillison ML Trotti AM Harris J Eisbruch A Harari PM Adelstein DJ Jordan RCK Zhao W Sturgis EM Burtness B Ridge JA Ringash J Galvin J Yao M Koyfman SA Blakaj DM Razaq MA Colevas AD Beitler JJ Jones CU Dunlap NE Seaward SA Spencer S Galloway TJ Phan J Dignam JJ Le QT Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet . 2019 Jan 5;393(10166):40-50
[PubMed ID: 30449625]
Zhang QE Wu Q Harari PM Rosenthal DI Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216. Head Neck . 2019 Jan;41(1):37-45
[PubMed ID: 30549358]
Gay HA Santiago R Gil B Remedios C Montes PJ López-Araujo J Chévere CM Imbert WS White J Arthur DW Horton JK Jagsi R Rabinovich R Beriwal S Viswanathan A Erickson BA Rengan R Palma D Loo BW Jr Kavanaugh JA Bradley J Yom SS Harari PM Lee Burnett O 3rd Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients. Pract Radiat Oncol . 2019 Sep - Oct;9(5):305-321
[PubMed ID: 30999000]
Elsaid MY Shahi A Wang AR Baiu DC Li C Werner LR Singhal S Hall LT Weichert JP Armstrong EA Bednarz BP Harari PM Iyer G Otto M Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther . 2018 Nov;17(11):2320-2328
[PubMed ID: 30108133]
McDaniel NK Cummings CT Iida M Hülse J Pearson HE Vasileiadi E Parker RE Orbuch RA Ondracek OJ Welke NB Kang GH Davies KD Wang X Frye SV Earp HS Harari PM Kimple RJ DeRyckere D Graham DK Wheeler DL MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Mol Cancer Ther . 2018 Nov;17(11):2297-2308
[PubMed ID: 30093568]
Thompson JD Harari PM Hartig GK Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients? Laryngoscope Investig Otolaryngol . 2018 Dec;3(6):446-449
[PubMed ID: 30599028]